Attachments
PDF
Share price
+1.39%
Turnover
0.34 MDKK
Calendar
| Est. time* | ||
| 2026-02-03 | 08:00 | Year-end Report 2025 |
| 2025-10-21 | - | Quarterly Report 2025-Q3 |
| 2025-07-22 | - | Quarterly Report 2025-Q2 |
| 2025-04-29 | - | Quarterly Report 2025-Q1 |
| 2025-03-13 | - | Ex-date Ordinary Dividend EMBLA 0.00 DKK |
| 2025-03-12 | - | Annual General meeting |
| 2025-02-05 | - | Year-end Report 2024 |
| 2024-10-22 | - | Quarterly Report 2024-Q3 |
| 2024-07-23 | - | Quarterly Report 2024-Q2 |
| 2024-04-23 | - | Quarterly Report 2024-Q1 |
| 2024-03-13 | - | Annual General meeting |
| 2024-03-13 | - | Ex-date Ordinary Dividend EMBLA 0.00 DKK |
| 2024-03-12 | - | Annual General meeting |
| 2024-01-30 | - | Year-end Report 2023 |
| 2023-10-24 | - | Quarterly Report 2023-Q3 |
| 2023-07-25 | - | Quarterly Report 2023-Q2 |
| 2023-04-25 | - | Quarterly Report 2023-Q1 |
| 2023-03-13 | - | Ex-date Ordinary Dividend EMBLA 0.00 DKK |
| 2023-03-10 | - | Annual General meeting |
| 2023-01-31 | - | Year-end Report 2022 |
| 2022-10-25 | - | Quarterly Report 2022-Q3 |
| 2022-07-21 | - | Quarterly Report 2022-Q2 |
| 2022-04-26 | - | Quarterly Report 2022-Q1 |
| 2022-03-09 | - | Ex-date Ordinary Dividend EMBLA 0.00 DKK |
| 2022-03-08 | - | Annual General meeting |
| 2022-02-01 | - | Year-end Report 2021 |
| 2021-10-26 | - | Quarterly Report 2021-Q3 |
| 2021-07-22 | - | Quarterly Report 2021-Q2 |
| 2021-04-27 | - | Quarterly Report 2021-Q1 |
| 2021-03-09 | - | Ex-date Ordinary Dividend EMBLA 0.00 DKK |
| 2021-03-08 | - | Annual General meeting |
| 2021-02-02 | - | Year-end Report 2020 |
| 2020-10-27 | - | Quarterly Report 2020-Q3 |
| 2020-07-23 | - | Quarterly Report 2020-Q2 |
| 2020-04-30 | - | Quarterly Report 2020-Q1 |
| 2020-03-13 | - | Ex-date Ordinary Dividend EMBLA 0.15 DKK |
| 2020-03-12 | - | Annual General meeting |
| 2020-02-04 | - | Year-end Report 2019 |
| 2019-10-22 | - | Quarterly Report 2019-Q3 |
| 2019-07-25 | - | Quarterly Report 2019-Q2 |
| 2019-04-30 | - | Quarterly Report 2019-Q1 |
| 2019-03-08 | - | Ex-date Ordinary Dividend EMBLA 0.14 DKK |
| 2019-03-07 | - | Annual General meeting |
| 2019-02-05 | - | Year-end Report 2018 |
| 2018-10-24 | - | Quarterly Report 2018-Q3 |
| 2018-07-25 | - | Quarterly Report 2018-Q2 |
| 2018-04-25 | - | Quarterly Report 2018-Q1 |
| 2018-03-09 | - | Ex-date Ordinary Dividend EMBLA 0.13 DKK |
| 2018-03-08 | - | Annual General meeting |
| 2018-02-05 | - | Year-end Report 2017 |
| 2017-10-24 | - | Quarterly Report 2017-Q3 |
| 2017-07-25 | - | Quarterly Report 2017-Q2 |
| 2017-04-27 | - | Quarterly Report 2017-Q1 |
| 2017-03-10 | - | Ex-date Ordinary Dividend EMBLA 0.12 DKK |
| 2016-03-11 | - | Ex-date Ordinary Dividend EMBLA 0.12 DKK |
| 2016-03-10 | - | Annual General meeting |
| 2016-02-02 | - | Year-end Report 2015 |
| 2015-10-22 | - | Quarterly Report 2015-Q3 |
| 2015-07-23 | - | Quarterly Report 2015-Q2 |
| 2015-04-29 | - | Quarterly Report 2015-Q1 |
| 2015-03-12 | - | Annual General meeting |
| 2015-02-05 | - | Year-end Report 2014 |
| 2014-10-24 | - | Analyst Meeting 2014 |
| 2014-10-23 | - | Quarterly Report 2014-Q3 |
| 2014-07-25 | - | Analyst Meeting 2014 |
| 2014-07-24 | - | Quarterly Report 2014-Q2 |
| 2014-04-30 | - | Analyst Meeting 2014 |
| 2014-04-29 | - | Quarterly Report 2014-Q1 |
| 2014-03-14 | - | Annual General meeting |
| 2014-02-05 | - | Year-end Report 2013 |
| 2013-10-24 | - | Analyst Meeting 2013 |
| 2013-10-23 | - | Quarterly Report 2013-Q3 |
| 2013-07-24 | - | Quarterly Report 2013-Q2 |
| 2013-04-24 | - | Quarterly Report 2013-Q1 |
| 2013-03-15 | - | Annual General meeting |
| 2013-02-06 | - | Year-end Report 2012 |
| 2012-11-28 | - | Capital Market Day 2012 |
| 2012-11-27 | - | Capital Market Day 2012 |
| 2012-10-24 | - | Analyst Meeting 2012 |
| 2012-10-23 | - | Quarterly Report 2012-Q3 |
| 2012-07-25 | - | Quarterly Report 2012-Q2 |
| 2012-04-24 | - | Quarterly Report 2012-Q1 |
| 2012-03-16 | - | Annual General meeting |
| 2012-02-08 | - | Year-end Report 2011 |
| 2011-10-27 | - | Quarterly Report 2011-Q3 |
| 2011-07-28 | - | Quarterly Report 2011-Q2 |
| 2011-03-04 | - | Annual General meeting |
Description
| Country | Iceland |
|---|---|
| List | Large Cap Copenhagen |
| Sector | Health care |
| Industry | Medical technology |
Interested in the company’s key figures?
Analyze the company in Börsdata!
Who owns the company?
Find all ownership data in Holdings!
Reykjavik, Iceland/Copenhagen, Denmark, January 9, 2025. Embla Medical (Nasdaq Copenhagen: EMBLA) will publish its Q4/Full Year 2024 Report on 5 February 2025 at 7:00 CET. A conference call will be hosted on the same day at 9:00 CET / 8:00 GMT / 3:00am EST.
The event will be hosted by Sveinn Solvason, President and CEO, and G. Arna Sveinsdottir, CFO. The call will include a review of the quarterly and full year results and will be held in English.
Slides used in the presentation will be made available on the company website at the following link: https://www.emblamedical.com/investors
To participate in the telephone conference, please use the dial-in details provided below:
DK: +45 78 76 84 90
SE: +46 31-311 50 03
UK: +44 20 3769 6819
US: +1 646 787 0157
Participant access code: 274982
The webcast will be available through following link: Embla Medical Q4/FY 2024 webcast
Financial calendar and events 2025
9 Jan 2025 SEB Nordic Seminar, Copenhagen
5 Feb 2025 2024 Annual Report
5 Feb 2025 Q4/FY presentation and virtual Q&A (HCA Capital)
6 Feb 2025 Q4/FY Road Show Copenhagen (ABG)
7 Feb 2025 Q4/FY Road Show Stockholm (ABG)
10 Feb 2025 Q4/FY Road Show London (Intron Health)
11-12 Feb 2025 Q4/FY Road Show New York City/East Coast (SEB)
26-27 Feb 2025 Q4/FY Road Show Benelux (DNB)
12 Mar 2025 2025 Annual General Meeting
26-27 Mar 2025 DNB Nordic-American Healthcare Conference, New York City
29 April 2025 Interim report Q1 2025
28 May 2025 Redeye Orthopedic Event, Stockholm
3 June 2025 Carnegie Healthcare Day, Paris
22 July 2025 Interim report Q2 2025
27 Aug 2025 Økonomisk Ugebrev Life Science Conference, Copenhagen
4-5 Sept 2025 Goldman Sachs MedTech conference, London
16 Sept 2025 Pareto Securities Annual Healthcare Conference, Stockholm
21 Oct 2025 Interim Report Q3 2025
If you wish to receive Embla Medical press releases by e-mail, please register here
For further information please contact
Klaus Sindahl
Head of Investor Relations
M: +45 5363 0134
About Embla Medical
Embla Medical (Nasdaq Copenhagen: EMBLA) is a leading global provider of innovative mobility solutions that help people live a Life Without Limitations®. Home to several leading brands, Embla Medical is dedicated to improving people`s mobility by providing prosthetics, neuro orthotics, bracing & supports and patient care through a global network of orthotic & prosthetic facilities. Embla Medical is committed to sustainable business practices renowned for positively impacting people`s health and well-being.